• Home
  • About Us
    • About Us
    • Subscribe
    • Privacy Policy
  • Advertise
    • Advertise On IP Watch
    • Editorial Calendar
  • Videos
  • Links
  • Help

Intellectual Property Watch

Original news and analysis on international IP policy

  • Copyright
  • Patents
  • Trademarks
  • Opinions
  • People News
  • Venues
    • Bilateral/Regional Negotiations
    • ITU/ICANN
    • United Nations – other
    • WHO
    • WIPO
    • WTO/TRIPS
    • Africa
    • Asia/Pacific
    • Europe
    • Latin America/Caribbean
    • North America
  • Themes
    • Access to Knowledge/ Open Innovation & Science
    • Food Security/ Agriculture/ Genetic Resources
    • Finance
    • Health & IP
    • Human Rights
    • Internet Governance/ Digital Economy/ Cyberspace
    • Lobbying
    • Technical Cooperation/ Technology Transfer
  • Health Policy Watch

WIPO, IFPMA Speaker Says Despite Trump Actions, He Would Be US Science Envoy

24/08/2017 by William New, Intellectual Property Watch 1 Comment

Share this:

  • Click to share on Twitter (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to email this to a friend (Opens in new window)
  • Click to print (Opens in new window)

A United States State Department science envoy quit yesterday in protest over US President Donald Trump’s pullout from the Paris climate accord and defensive comments after violence at a white nationalist rally in Charlottesville, Virginia. But according to a press report, Peter Hotez, a past science adviser who has been a featured speaker of a UN agency and pharmaceutical industry group in Geneva, is stepping up to offer his services without concern for Trump’s actions.

According to a report by the Guardian, Daniel Kammen sent a letter of resignation yesterday with the first letters of each paragraph spelling out “IMPEACH”. Kammen, one of three State Department science envoys, is a professor at the University of California Berkeley, and director of the Renewable and Appropriate Energy Laboratory (RAEL).

“Your actions to date have, sadly, harmed the quality of life in the United States, our standing abroad, and the sustainability of the planet,” he wrote.

On Hotez, the Guardian said:

“Peter Hotez, dean of the National School of Tropical Medicine at the Baylor College of Medicine in Texas, served as envoy in 2015 and 2016 and said he has been in contact with the state department about possibly returning. He would be willing to do so even after Trump’s post-Charlottesville statements, he told Reuters on Wednesday.”

“’Despite those comments I think it’s important to be willing to serve the United States,’ Hotez said.”

“Trump’s comments sparked a wave of defections of chief executives from White House advisory councils, leading to their disbanding, and earned condemnations from Republicans and Democrats alike,” the Guardian said. Departing CEOs included the head of a large pharmaceutical company.

[Update:] A spokesperson from the Baylor College of Medicine has clarified to Intellectual Property Watch: “Dr. Hotez’s focus was on discussing his role as a US Science Envoy and the importance of vaccine diplomacy throughout the world. His focus was not to discuss either administration, but solely to talk about the role of US Science Envoy under any administration.”

Also, a representative for the IFPMA clarified that Hotez was not and is not an adviser to the industry group, but was simply an invited speaker.  [end update]

Peter Hotez

Hotez was the keynote speaker at the Geneva-based International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) 2016 General Assembly. He also was a featured speaker at an event in 2015 of the Global Challenges Division at the UN World Intellectual Property Organization and was the subject of 2016 laudatory feature interview in the WIPO Magazine, in both cases recognised for his expertise in neglected tropical diseases.

Hotez has also been the head of a WIPO Advisory Committee established in 2016 to guide the expansion of WIPO Re:Search over 5 years, according to an Intellectual Property Watch interview with Jennifer Dent, president of BIO Ventures for Global Health (BVGH).

Intellectual Property Watch also has written about Hotez’s views on neglected tropical diseases (IPW, WIPO, 2 November 2015).

Hotez was not reached for comment by press time.

 

Image Credits: Peter Hotez

Share this:

  • Click to share on Twitter (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to email this to a friend (Opens in new window)
  • Click to print (Opens in new window)

Related

William New may be reached at wnew@ip-watch.ch.

Creative Commons License"WIPO, IFPMA Speaker Says Despite Trump Actions, He Would Be US Science Envoy" by Intellectual Property Watch is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Filed Under: IP Policies, Language, Themes, Venues, English, Health Policy Watch, Human Rights, Lobbying, North America, Patents/Designs/Trade Secrets, Regional Policy

Trackbacks

  1. Links 25/8/2017: GIMP 2.9.6 Released, SUSE Cushions Btrfs | Techrights says:
    25/08/2017 at 7:28 am

    […] WIPO, IFPMA Adviser Sees No Problem With Trump Comments, May Become US Science Envoy […]

    Reply

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

  • Email
  • Facebook
  • LinkedIn
  • RSS
  • Twitter
  • Vimeo
My Tweets

Perspectives on the US

In US, No Remedies For Growing IP Infringements

US IP Law – Big Developments On The Horizon In 2019

More perspectives on the US...

Supported Series: Civil Society And TRIPS Flexibilities

Civil Society And TRIPS Flexibilities Series – Translations Now Available

The Myth Of IP Incentives For All Nations – Q&A With Carlos Correa

Read the TRIPS flexibilities series...

Top Global Health stories

New WHO Director Tedros’s Opening Vision: People First

Enter The African Medicines Agency, Continent’s First Super-Regulator?

More health stories...

Paid Content

Interview With Peter Vanderheyden, CEO Of Article One Partners

More paid content...

IP Delegates in Geneva

  • IP Delegates in Geneva
  • Guide to Geneva-based Public Health and IP Organisations

All Story Categories

Other Languages

  • Français
  • Español
  • 中文
  • اللغة العربية

Archives

  • Archives
  • Monthly Reporter

Staff Access

  • Writers

Sign up for free news alerts

This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy

Copyright © 2025 · Global Policy Reporting

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.